JP2025518052A5 - - Google Patents

Info

Publication number
JP2025518052A5
JP2025518052A5 JP2024569534A JP2024569534A JP2025518052A5 JP 2025518052 A5 JP2025518052 A5 JP 2025518052A5 JP 2024569534 A JP2024569534 A JP 2024569534A JP 2024569534 A JP2024569534 A JP 2024569534A JP 2025518052 A5 JP2025518052 A5 JP 2025518052A5
Authority
JP
Japan
Prior art keywords
aav vector
vector according
seq
amino acid
aav
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024569534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025518052A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/066865 external-priority patent/WO2023230409A1/en
Publication of JP2025518052A publication Critical patent/JP2025518052A/ja
Publication of JP2025518052A5 publication Critical patent/JP2025518052A5/ja
Pending legal-status Critical Current

Links

JP2024569534A 2022-05-24 2023-05-11 Xlmtmを処置するための組成物 Pending JP2025518052A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263345144P 2022-05-24 2022-05-24
US63/345,144 2022-05-24
PCT/US2023/066865 WO2023230409A1 (en) 2022-05-24 2023-05-11 Compositions for treating xlmtm

Publications (2)

Publication Number Publication Date
JP2025518052A JP2025518052A (ja) 2025-06-12
JP2025518052A5 true JP2025518052A5 (enExample) 2026-05-07

Family

ID=88920170

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024569534A Pending JP2025518052A (ja) 2022-05-24 2023-05-11 Xlmtmを処置するための組成物

Country Status (12)

Country Link
US (1) US20260009049A1 (enExample)
EP (1) EP4532516A4 (enExample)
JP (1) JP2025518052A (enExample)
KR (1) KR20250039324A (enExample)
CN (1) CN119630687A (enExample)
AU (1) AU2023276729A1 (enExample)
CA (1) CA3256727A1 (enExample)
CL (1) CL2024003578A1 (enExample)
CO (1) CO2024016313A2 (enExample)
IL (1) IL317433A (enExample)
MX (1) MX2024014499A (enExample)
WO (1) WO2023230409A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20260114566A (ko) * 2023-11-14 2026-07-22 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 심근 및 골격근-특이적 표적화 모티프를 갖는 조성물 및 이의 용도
WO2026030244A1 (en) * 2024-07-30 2026-02-05 Kate Therapeutics, Inc. Adeno-associated virus compositions for the treatment of limb girdle muscular dystrophy 2a
WO2026122921A1 (en) 2024-12-05 2026-06-11 The Trustees Of The University Of Pennsylvania Gene therapy for barth syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1668143B1 (en) * 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
US20210355509A1 (en) * 2018-08-07 2021-11-18 The Children's Hospital Of Philadelphia Alternative splicing regulation of gene expression and therapeutic methods
WO2022020616A1 (en) * 2020-07-22 2022-01-27 The Broad Institute, Inc. Engineered muscle targeting compositions

Similar Documents

Publication Publication Date Title
CN111902539B (zh) 杂合调控元件
JP2022551986A5 (enExample)
ES2580044T3 (es) Método de incremento de la función de un vector de AAV
US20230190965A1 (en) Treatment of glycogen storage disease iii
JP2023534999A5 (enExample)
JP2022547197A5 (enExample)
JP2021512649A5 (enExample)
JP2018531609A5 (enExample)
JP2022523679A5 (enExample)
JP2007507223A5 (enExample)
US20210198692A1 (en) Adeno-associated viral vector-mediated gene therapy for treating fragile x-associated disorders
JP2022541070A5 (enExample)
JP2023501897A5 (enExample)
JP2022551744A5 (enExample)
WO2020208032A1 (en) Hybrid promoters for muscle expression
JP2023537358A5 (enExample)
JP2025500347A5 (enExample)
IL293431A (en) Transgene cassettes designed to express human mecp2 gene
JP2022521432A5 (enExample)
CA3107572A1 (en) Mini-gde for the treatment of glycogen storage disease iii
JP2023520763A5 (enExample)
JP2021534766A5 (enExample)
JP2022531892A5 (enExample)
JP2021521782A5 (enExample)
JP2025518052A (ja) Xlmtmを処置するための組成物